Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Microscopic Polyangiitis
- PR3-AAV Resilient Remission or PRRR
- Hydroxychloroquine in ANCA Vasculitis Evaluation
- Efficacy and Safety of Rituximab in the Treatment of Good Prognosis Microscopic Polyangiitis
- Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis
- Study of IFX-1 to Replace Steroids in Patients With Granulomatosis With Polyangiitis and Microscopic Polyangiitis.
- Safety and Efficacy Study of IFX-1 in add-on to Standard of Care in Granulomatosis With Polyangiitis (GPA) and Microscopic Polyangiitis (MPA)
- Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis
- Low-dose Glucocorticoid Vasculitis Induction Study
- Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis
- A Study Evaluating the Safety and Efficacy of Rituximab in Combination With Glucocorticoids in Participants With Wegener's Granulomatosis or Microscopic Polyangitis
- A Phase IIa Study of Intravenous Rituximab in Pediatric Participants With Severe Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
- Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated Vasculitis
- Rituximab Vasculitis Maintenance Study
- Belimumab in Remission of VASculitis
- An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
- BIANCA-SC: A Study of the Efficacy, Safety, and Tolerability of Blisibimod in Addition to Methotrexate During Induction of Remission in Subjects With ANCA-Associated Small Vessel Vasculitis
- Plasma Exchange for Renal Vasculitis
- Alemtuzumab for ANCA Associated Refractory Vasculitis
- Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis
- Anti-Cytokine Therapy for Vasculitis
- Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides
- Efficacy Study of Two Treatments in the Remission of Vasculitis
- Association Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome)
- Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitides
- CellCept in p-ANCA Vasculitis
- CHUSPAN PAN BP Treatment of Polyarteritis Nodosa and Microscopic Polyangiitis Without Poor-Prognosis Factors
- Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years
- Intravenous Immunoglobulin After Relapse in Vasculitis
- IMPROVE: Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy in ANCA Associated Systemic Vasculitis
- RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides
- Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis
- Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA)